fda and tirzepatide Medscape | The approved Zepbound in December 2024 for the treatment of moderate-to-severe obstructive sleep apnea in patients with obesity after F.D.A. Approves New Obesity Drug

A study in rats in 2019 (Perovic, et al) found BPC 157 effective in promoting spinal cord injuries in rats

Lillys Trulicity is a once-weekly injectable treatment for type 2 diabetes that lowers blood sugar levels and supports weight loss

Why Bioavailability Becomes Critical As we get older, our digestive systems may also become more sensitive

The Clinical Default at Beyond Stem Cells For tendinopathy, ligament sprains, muscle injuries, joint pain, and most systemic indications, we default to subcutaneous injection

Plastic Surgery as a Solution Plastic surgery offers significant benefits in enhancing weight loss results, particularly for those dealing with gynecomastia